Skip to main content
GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System

Designed for the demands of TEVAR

Six key considerations to help you deliver optimal results.

Stent graft deployment

Unique angulation control

98% reported that the proximal wall apposition was acceptable at procedural completion1
Thumbnail of Hemodynamic Flow

Hemodynamic stability

NO rapid pacing used in 93% of cases1
why oversizing matters

Unique oversizing window

16-42mm Aortic Diameter Range as few as 5 sizes

video thumbnail

Conformability

Real world2 treatment* transection zero Type III endoleaks†, ruptures, device fractures, compressions, conversions
video thumbnail

Engineered to perform

Deliberately designed to enable long-term results you can trust

See how (1:00) 

* GORE® TAG® Conformable Device.
† Endoleak requiring intervention. No endoleaks persisted past one month or required intervention.

  1. W. L. Gore & Associates.  Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System.  NLM Identifier: NCT03286400.  Published September 18, 2017.  Updated December 17, 2020. Accessed February 23, 2021.   Available from: https://clinicaltrials.gov/ct2/show/NCT03286400
  2. GREAT is a prospective, observational, multicenter registry to actively track Gore commercial aortic endovascular device performance and associated patient outcomes in global markets with 10 years of follow-up. Data June 2017. Through 2-year follow-up. Transection n = 53.

241345600-EN